Skip to main content

Peer Review reports

From: Topical co‐administration of zoledronate with recombinant human bone morphogenetic protein-2 can induce and maintain bone formation in the bone marrow environment

Original Submission
15 Aug 2020 Submitted Original manuscript
20 Sep 2020 Reviewed Reviewer Report
1 Oct 2020 Reviewed Reviewer Report
20 Oct 2020 Author responded Author comments - Hideki Ueyama
Resubmission - Version 2
20 Oct 2020 Submitted Manuscript version 2
12 Dec 2020 Reviewed Reviewer Report
27 Dec 2020 Author responded Author comments - Hideki Ueyama
Resubmission - Version 3
27 Dec 2020 Submitted Manuscript version 3
7 Jan 2021 Author responded Author comments - Hideki Ueyama
Resubmission - Version 4
7 Jan 2021 Submitted Manuscript version 4
Publishing
11 Jan 2021 Editorially accepted
20 Jan 2021 Article published 10.1186/s12891-021-03971-w

You can find further information about peer review here.

Back to article page